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2. collapse with bronchioalveolarcell carcinoma (CwB), 3. adenocar-
cinoma cells (Cells), 4. ﬁbroblasts (F), and 5. mucus (M). Areas of 
air-type adenocarcinomas (in 49 cases) demonstrated predominantly 
C and/or CwB (C/CwB type: in 46 cases). Areas of solid-type adeno-
carcinomas (in 69 cases), in comparison, demonstrated predominantly 
Cells and/or Cells/F (Cells/F type: in 66 cases). We noted a statistically 
signiﬁcant difference between the histopathological ﬁndings of the 
areas of tumor opacity on mediastinal window images of air-type and 
solid-type tumors. In 34 cases, Cells/F type adenocarcinomas revealed 
microscopic evidence of metastasis (pleural involvement, vascular 
invasion, lymphatic permeation, or lymphnode metastsis). Whereas, no 
C/CwB type adenocarcinomas cases revealed any microscopic metasta-
sis. The prognosis of C/CwB after resection is better than for Cells/F.
Conclusion: We found that ‘Air-type’ adenocarcinomas demonstrated 
C/CwB type, and that ‘Solid-type’ adenocarcinomas demonastrated 
Cells/F type. We concluded that the histopathological ﬁndings of small 
pulmonary adenocarcinomas could be classiﬁed into two groups: 
C/CwB type and Cells/F type. The prognosis of C/CwB is better than 
for Cells/F.
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Background: The development of Lung Carcinoma (LC) is accompa-
nied by ﬁeld changes of histological and chromosomal abnormalities in 
the airway mucosa. Neither histological grade nor markers of chro-
mosomal abnormalities in preneoplastic epithelial lesions have been 
adequately validated as predictors of invasive LC. 
Methods: Histological dysplasia score and chromosomal aneusomy 
measured by FISH analysis were compared as correlates of invasive 
LC in a case-control study of 44 individuals with LC (cases) and 90 
individuals without LC (controls). We used bronchial biopsy samples 
from subjects found by LIFE or white light bronchoscopy to have had 
moderate dysplasia (MD), severe dysplasia (SD) or carcinoma in situ 
(CIS). Tissue samples were reviewed by the study pathologist, the 
grades of preneoplastic change were veriﬁed and the appropriate areas 
in each histological slide were selected for FISH analysis. A 4-color 
FISH probe was used for aneusomy detection targeting centromere 6, 
5p15.2, 7p12 (EGFR) and 8q24 (CMYC). Three or more copies for two 
or more of these DNA targets indicated an aneusomic cell. Premalig-
nant lesions were classiﬁed as aneusomic when displaying aneusomic 
cells above the threshold deﬁned in normal bronchial epithelium (mean 
+ 3 SD). 
Results: The population included 104 males and 30 females with a 
mean age of 64 years and a mean smoking history of 62 pack-years. 
There was no difference in mean age, sex distribution or pack-years 
of smoking between LC cases and controls, but cases had a higher 
frequency of current smokers (p=0.05). Thirty two had CIS as the 
highest histological grade of mucosal abnormality, 48 had SD and 54 
MD. The strongest correlate with invasive LC was CIS by histological 
examination (OR=12.5, 95% CI 4.1 to 38.1). Chromosomal aneusomy 
was seen in 64% of the LC cases but in only 31% of the controls. (OR 
= 4.6, 95% CI 2.0 to 10.9). The proportion of subjects with chromo-
somal aneusomy increased from moderate dysplasia (22.2%) to severe 
dysplasia (41.7%) and CIS lesions (71.9%) and showed a similar trend 
for cases and controls. Presence of aneusomy slightly increased the risk 
for LC in MD (OR=1.91, 95% CI 0.26 to 13.8) but was a substantial 
impacting factor in subjects with SD (OR=7.06, 95% CI 0.82 to 60.1) 
and CIS (OR=5.93, 95% CI 0.5 to 69.7).
Conclusions: CIS on histological examination and abnormal FISH 
analysis are both associated with lung cancer cross-sectionally. Future 
studies need to examine these biomarkers prospectively, and to assess 
their interaction in predicting lung cancer risk. 
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Background: The E2F1 transcription factor is a cell cycle and onco-
genic protein which plays ambiguous role in promoting proliferation 
or apoptosis depending on histological cell type of lung cancer (Salon 
et al. Cell Death and Differ. 2006). Accordingly, its activity is tightly 
controlled by transcriptional and post-transcriptional events in which 
the ubiquitin-proteasome pathway mediated by SCF complexes such 
as Skp2 and Cullin 1 (CUL1) proteins play a role in its degradation. 
We have previously identiﬁed differential pattern of E2F1 protein 
expression in human lung cancer with high expression in high grade 
neuroendocrine tumors, in contrast with low or no expression in non 
small cell carcinoma and in carcinoids (small cell lung carcinoma and 
large cell neuroendocrine carcinoma) (Eymin et al. Oncogene 2001). 
In order to investigate the role of proteasome degradation in E2F1 
expression and activity we analyzed the components of SCF complex 
(Skp2 and CUL1) to understand their role on expression of E2F1 and 
its transcriptional targets cyclin E, important regulators of cell cycle at 
G1-S transition.
Methods: Using immunohistochemistry and immunoblotting we ana-
lyzed 128 lung tumors of all histological types for the relationship link-
ing E2F1 and two components CUL1 and Skp2 of the ubiquitin-protein 
ligase SCFSkp2 <involved in E2F1 proteolysis and the consequence on 
cyclin E level expression.
Results: Skp2 protein was more often overexpressed in high grade neu-
roendocrine (HGNE) carcinoma (46/54; 86 %) than in NSCLC (16/50; 
32 %) (p<0.0001), and undetectable in 25/25 carcinoids. Overexpres-
sion of E2F1 and Skp2 proteins were directly correlated in HGNE 
tumors where Skp2 overexpression was correlated with advanced stage 
(p<0.0001) and nodal metastasis (p<0.0001). There was a signiﬁcant 
correlation between Skp2 and Ki67 across histological types (p=0.01). 
No correlation was found between E2F1 and CUL1. In in vitro cellular 
models we provided evidence that Skp2 is a novel transcriptional target 
of E2F1. Skp2 interacts with E2F1 and stimulates its transcriptional 
activity toward the cyclin E promoter. Consistently, we found a cor-
relation between Skp2 and cyclin E (p<0.0001) and between E2F1 and 
cyclin E in neuroendocrine lung tumors (p=0.0001). In contrast, CUL1 
